RealFeedApp Epigenetic reprogramming resets cellular aging state
The trial demonstrates that partial epigenetic reprogramming using Yamanaka factors resets cellular epigenetics to a youthful state without triggering dedifferentiation. However, the method demands precise control over exposure duration to avoid forming induced pluripotent stem cells and teratomas.
- Field
- ageing and longevity
- What they did
- Researchers from Life Biosciences conducted the first clinical trial of epigenetic reprogramming to restore a youthful state to cells without converting them into stem cells.
- Why it matters
- This approach enables the safe application of therapy to restore tissue functions in specific areas, avoiding the risk of tumor formation.
#epigenetic reprogramming#yamanaka factors#clinical trial#senescence#life biosciences
